|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.14 USD | +0.15% |
|
+2.13% | +35.17% |
| 16/07 | TD Cowen Adjusts Price Target on Boston Scientific to $86 From $77 | MT |
| 16/07 | Truist Raises Price Target on Boston Scientific to $90 From $86, Maintains Buy Rating | MT |
Jan 8 (Reuters) - Boston Scientific said on Monday it had agreed to buy medtech company Axonics Inc for $3.7 billion. (Reporting by Sriparna Roy in Bengaluru; Editing by Sriraj Kalluvila)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 78.14 USD | +0.15% | +2.13% | 11TCr | ||
| 67.97 USD | +0.18% | +0.71% | 346.77Cr | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +35.17% | 11TCr | |
| +4.64% | 21TCr | |
| +8.99% | 19TCr | |
| +29.83% | 16TCr | |
| +2.32% | 6.55TCr | |
| +15.06% | 5.29TCr | |
| -6.47% | 4.53TCr | |
| -2.14% | 3.97TCr | |
| +6.88% | 3.77TCr | |
| +20.22% | 3.04TCr |
BOSTON SCIENTIFIC CORPORATION 
